Related references
Note: Only part of the references are listed.Simplified Approach to the Treatment of Uncomplicated Hypertension A Cluster Randomized, Controlled Trial
Ross D. Feldman et al.
HYPERTENSION (2009)
Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination
P. Trenkwalder et al.
BLOOD PRESSURE (2008)
Using Fixed-Dose Combination Therapies to Achieve Blood Pressure Goals
Steven G. Chrysant
CLINICAL DRUG INVESTIGATION (2008)
Does earlier attainment of blood pressure goal translate into fewer cardiovascular events?
Samar A. Nasser et al.
CURRENT HYPERTENSION REPORTS (2008)
Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX-FAST) Study
Yves Allemann et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
Hypertension Control in the Elderly
Joel M. Neutel et al.
JOURNAL OF CLINICAL HYPERTENSION (2008)
Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study
Maurizio Destro et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2008)
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
Kenneth Jamerson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
2007 guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension
Thomas Philipp et al.
CLINICAL THERAPEUTICS (2007)
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension
Don Poldermans et al.
CLINICAL THERAPEUTICS (2007)
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults
James L. Pool et al.
CLINICAL THERAPEUTICS (2007)
Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004
Kwok Leung Ong et al.
HYPERTENSION (2007)
Medication adherence and persistence as the cornerstone of effective anti hypertensive therapy
Michel Burnier
AMERICAN JOURNAL OF HYPERTENSION (2006)
Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension:: An 8-week, randomized, double-blind, parallel-group trial
Y Lacourcière et al.
CLINICAL THERAPEUTICS (2005)
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with Amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors:: The VAST study
LM Ruilope et al.
CLINICAL THERAPEUTICS (2005)
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
B Williams et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
CJ Pepine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
I Hajjar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Rationale for fixed-dose combinations in the treatment of hypertension - The cycle repeats
DA Sica
DRUGS (2002)